Exact Mass: 653.2756

Exact Mass Matches: 653.2756

Found 54 metabolites which its exact mass value is equals to given mass value 653.2756, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Rifamycin W-hemiacetal

Rifamycin W-hemiacetal

C35H43NO11 (653.2836)


   
   

2-Oxa-4,7,12-triazatridecan-13-oic acid, 9-hydroxy-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-1-(2-pyridinyl)-, 3-pyridinylmethyl ester, (5S,8S,9S,11S)-

N-[3-Hydroxy-5-({hydroxy[(pyridin-3-yl)methoxy]methylidene}amino)-1,6-diphenylhexan-2-yl]-2-({hydroxy[(pyridin-2-yl)methoxy]methylidene}amino)-3-methylbutanimidate

C37H43N5O6 (653.3213)


   

Glucosaminylmuramyl-2-alanine-D-isoglutamine

2-{[2-({2-[(3-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-4-yl)oxy]-1-hydroxypropylidene}amino)-1-hydroxypropylidene]amino}-4-(C-hydroxycarbonimidoyl)butanoate

C25H43N5O15 (653.2756)


   

2,6,14-Triacetoxy-1-benzoyloxydihydro-9-nicotinoyloxy-beta-agarofuran

2,6,14-Triacetoxy-1-benzoyloxydihydro-9-nicotinoyloxy-beta-agarofuran

C34H39NO12 (653.2472)


   

1beta,5alpha,11-triacetoxy-7beta-benzoyl-4alpha-hydroxy-8beta-nicotinoyl-dihydroagarofuran|1??,5??,11-Triacetoxy-7??-benzoyl-4??-hydroxy-8??-nicotinoyl-dihydroagarofuran

1beta,5alpha,11-triacetoxy-7beta-benzoyl-4alpha-hydroxy-8beta-nicotinoyl-dihydroagarofuran|1??,5??,11-Triacetoxy-7??-benzoyl-4??-hydroxy-8??-nicotinoyl-dihydroagarofuran

C34H39NO12 (653.2472)


   

14-desoxo-3-O-propionyl-5,15-di-O-acetyl-7-O-nicotinoyl-myrsinol-14beta-acetate

14-desoxo-3-O-propionyl-5,15-di-O-acetyl-7-O-nicotinoyl-myrsinol-14beta-acetate

C35H43NO11 (653.2836)


   

1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-benzoyloxy-11-acetoxy-4beta-hydroxydihydro-beta-agarofuran|1??-Nicotinoyloxy-2??-acetoxy-6??-acetoxy-9??-benzoyloxy-11-acetoxy-4??-hydroxydihydro-??-agarofuran|2,6,14-Triacetoxy-9-(benzoyloxy)dihydro-1-nicotinoyloxy-beta-agarofuran

1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-benzoyloxy-11-acetoxy-4beta-hydroxydihydro-beta-agarofuran|1??-Nicotinoyloxy-2??-acetoxy-6??-acetoxy-9??-benzoyloxy-11-acetoxy-4??-hydroxydihydro-??-agarofuran|2,6,14-Triacetoxy-9-(benzoyloxy)dihydro-1-nicotinoyloxy-beta-agarofuran

C34H39NO12 (653.2472)


   

2-O-beta-D-glucopyranosyldemethylalangiside

2-O-beta-D-glucopyranosyldemethylalangiside

C30H39NO15 (653.232)


   

Protostreptovaricin III

Protostreptovaricin III

C36H47NO10 (653.32)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins

   

His Leu Asp Gln Gln

His Leu Asp Gln Gln

C27H43N9O10 (653.3133)


   

Ferrioxamine E [M+Fe-2H]

Ferrioxamine E [M+Fe-2H]

C27H45FeN6O9 (653.2597)


   

PHHdiA-PS

1-hexadecanoyl-2-(4-hydroxy-6-carboxy-5E-hexenoyl)-sn-glycero-3-phosphoserine

C29H52NO13P (653.3176)


   

Fmoc-Trp(Boc)-Ser(psi(Me,Me)pro)-OH

Fmoc-Trp(Boc)-Ser(psi(Me,Me)pro)-OH

C37H39N3O8 (653.2737)


   

Precursor of cefcapene diisopropylanmine salt

Precursor of cefcapene diisopropylanmine salt

C29H43N5O8S2 (653.2553)


   

2-Oxa-4,7,12-triazatridecan-13-oic acid, 9-hydroxy-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-1-(2-pyridinyl)-, 3-pyridinylmethyl ester, (5S,8S,9S,11S)-

2-Oxa-4,7,12-triazatridecan-13-oic acid, 9-hydroxy-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-1-(2-pyridinyl)-, 3-pyridinylmethyl ester, (5S,8S,9S,11S)-

C37H43N5O6 (653.3213)


   

7,8-Didehydro-3-methylprostreptovaricin

7,8-Didehydro-3-methylprostreptovaricin

C36H47NO10 (653.32)


   

ansavaricin E

ansavaricin E

C36H47NO10 (653.32)


   

2-[2-[2-[3-Acetamido-5-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid

2-[2-[2-[3-Acetamido-5-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid

C25H43N5O15 (653.2756)


   
   
   

A 80987

2-Oxa-4,7,12-triazatridecan-13-oic acid, 9-hydroxy-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-1-(2-pyridinyl)-, 3-pyridinylmethyl ester, (5S,8S,9S,11S)-

C37H43N5O6 (653.3213)


   

ferrioxamine E

ferrioxamine E

C27H45FeN6O9 (653.2597)


An Fe(III)-complexed hydroxamate siderophore consisting of norcardamine (desferrioxamine E) complexed to iron(III).

   
   
   
   
   
   
   
   
   

ST 24:4;O8;HexNAc

ST 24:4;O8;HexNAc

C32H47NO13 (653.3047)


   

(1s,2r,4s,5r,6s,7s,8r,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate

(1s,2r,4s,5r,6s,7s,8r,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

(3s,4r,4as,5ar)-4-ethenyl-8-hydroxy-3,7-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

(3s,4r,4as,5ar)-4-ethenyl-8-hydroxy-3,7-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C30H39NO15 (653.232)


   

(1r,2s,4s,5s,6s,7s,9s,12s)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

(1r,2s,4s,5s,6s,7s,9s,12s)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

(1s,2s,3s,4r,5r,7s,8s,9s,10s,11r,14s)-2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

(1s,2s,3s,4r,5r,7s,8s,9s,10s,11r,14s)-2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

C35H43NO11 (653.2836)


   

2-({2-[(1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene)amino]-1,3-dihydroxypropylidene}amino)-n-{2-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-5-(n-hydroxyformamido)pentanimidic acid

2-({2-[(1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene)amino]-1,3-dihydroxypropylidene}amino)-n-{2-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)


   

1α-nicotinoyloxy-2α-acetoxy-6β-acetoxy-9β-benzoyloxy-11-acetoxy-4β-hydroxydihydro-β-agarofuran

NA

C34H39NO12 (653.2472)


{"Ingredient_id": "HBIN002312","Ingredient_name": "1\u03b1-nicotinoyloxy-2\u03b1-acetoxy-6\u03b2-acetoxy-9\u03b2-benzoyloxy-11-acetoxy-4\u03b2-hydroxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C34H39NO12","Ingredient_Smile": "CC(=O)OCC12C(CC3C(C1(C(CC(C2OC(=O)C4=CN=CC=C4)OC(=O)C)(C)O)OC3(C)C)OC(=O)C)OC(=O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15525","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,2r,3r,4s,5s,7r,8s,9r,10r,11s,14r)-2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

(1r,2r,3r,4s,5s,7r,8s,9r,10r,11s,14r)-2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

C35H43NO11 (653.2836)


   

5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24,29-heptamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5(10),6,8,12,14,16,18-octaene-4,11,30-trione

6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24,29-heptamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5(10),6,8,12,14,16,18-octaene-4,11,30-trione

C35H43NO11 (653.2836)


   

(1s,2s,5s,6s,7s,8r,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

(1s,2s,5s,6s,7s,8r,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

C35H43NO11 (653.2836)


   

(4s)-4-{[(2r)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-4-{[(1s)-1-{[(1s)-1-(c-hydroxycarbonimidoyl)-2-methylpropyl]-c-hydroxycarbonimidoyl}-2-phenylethyl]-c-hydroxycarbonimidoyl}butanoic acid

(4s)-4-{[(2r)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-4-{[(1s)-1-{[(1s)-1-(c-hydroxycarbonimidoyl)-2-methylpropyl]-c-hydroxycarbonimidoyl}-2-phenylethyl]-c-hydroxycarbonimidoyl}butanoic acid

C32H43N7O8 (653.3173)


   

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-2-[2-(2-hydroxyphenyl)-2-oxoethoxy]ethylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-2-[2-(2-hydroxyphenyl)-2-oxoethoxy]ethylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)


   

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

4-ethenyl-8-hydroxy-3,7-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

4-ethenyl-8-hydroxy-3,7-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C30H39NO15 (653.232)


   

(2z,16z,18e,20s,23r,25s,27s,28r)-6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24,29-heptamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

(2z,16z,18e,20s,23r,25s,27s,28r)-6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24,29-heptamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

C35H43NO11 (653.2836)


   

(2r)-2-{[(2s)-2-{[(2s)-1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

(2r)-2-{[(2s)-2-{[(2s)-1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)


   

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(2-hydroxybenzoyloxy)propylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(2-hydroxybenzoyloxy)propylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)


   

2-{[2-({2-amino-1-hydroxy-2-[2-(2-hydroxyphenyl)-2-oxoethoxy]ethylidene}amino)-1,3-dihydroxypropylidene]amino}-n-{2-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-5-(n-hydroxyformamido)pentanimidic acid

2-{[2-({2-amino-1-hydroxy-2-[2-(2-hydroxyphenyl)-2-oxoethoxy]ethylidene}amino)-1,3-dihydroxypropylidene]amino}-n-{2-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)